Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #89 on GlaxoSmithKline (GSK)
MinnieM
10/19/14 11:42 PM
#90 RE: Stock Guy777 #89
In large part because of worries that Ebola might be used as a biological weapon, vaccines that protect lab animals against the virus were already on the shelf when the outbreak began. Two are now being tested for safety in humans, and one of them could, if it is safe, be tested for efficacy quite soon, most likely in health-care workers in west Africa. Its maker, GlaxoSmithKline, could have 10,000 doses ready in a few months.